Expression of PD-L1 on circulating breast cancer cells: Correlation with clinicopathologic data and impact on prognosis

被引：3
|
作者：
Jacot, William [1 ]
Mazel, Martine [2 ]
Mollevi, Caroline [1 ]
Pouderoux, Stephane [1 ]
D'Hondt, Veronique [1 ]
Cayrefourcq, Laure [2 ]
Ducteil, Angelique [1 ]
Viala, Marie [1 ]
Maudelonde, Thierry [2 ]
Guiu, Severine [1 ]
Alix-Panabieres, Catherine [2 ]
机构：
[1] ICM Val dAurelle Paul Lamarque, Montpellier, France
[2] Univ Med Ctr, Montpellier, France
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4589
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PD-L1-expressing circulating breast cancer cells: correlation with tissue expression and clinical evolution
    Jacot, W.
    Mazel, M.
    Mollevi, C.
    Pouderoux, S.
    D'Hondt, V
    Cayrefourcq, L.
    Ducteil, A.
    Viala, M.
    Maudelonde, T.
    Guiu, S.
    Alix-Panabieres, C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 169 - 170
  • [32] Expression of PD-L1 is associated with poor prognosis in breast cancer: A meta-analysis
    Zhang, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with aggressiveness of tumor in breast cancer patients
    Schott, D.
    Pizon, M.
    Pachmann, U.
    Pachmann, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [34] The clinical impact of the PD-L1 expression and immunonutritional status on breast cancer survival
    Yamashita, Nami
    Tokunaga, Eriko
    Inoue, Yuka
    Saeki, Hiroshi
    Oki, Eiji
    Maehara, Yoshihiko
    CANCER SCIENCE, 2018, 109 : 521 - 521
  • [35] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2019, 32
  • [36] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2019, 99
  • [37] Clinicopathological significance of PD-L1 expression in colorectal cancer: Impact of PD-L1 expression on pFOXO1 expression
    Pyo, Jung-Soo
    Ko, Soo Hee
    Ko, Young San
    Kim, Nae Yu
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (02)
  • [38] IMPACT OF GENDER DIFFERENCES WITH PD-L1 EXPRESSION ON NSCLC CANCER PROGNOSIS: A STATISTICAL ANALYSIS
    Muthyala, Krithika
    Prodduturvar, Pranitha
    Ashfaq, Muhammad Areeb
    Escobar, Daisy
    CHEST, 2024, 166 (04) : 4252A - 4252A
  • [39] Expression of PD-L1 Family Members in Breast Cancer
    Badve, Sunil
    Saxena, Rashmil
    Gokmen-Polar, Yesim
    Yu, James
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 106 - 106
  • [40] Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors
    Ilieva, Nevena
    Pencheva, Mina
    Hadzhiev, Hristo
    Tashkova, Desislava
    Daskalova, Elena
    Georgiev, Petar
    Genova, Sylvia
    DIAGNOSTICS, 2024, 14 (23)
12345